Pharmaceutical Industry
Drugs
Chemical substances used in the treatment, prevention, or diagnosis of diseases.
Biologics
vaccines, proteins, antibodies
high nuclear weight >2000
manufactured using living organisms = plants, animals, cells
Small Molecules
low molecular weight <2000
manufactured through chemical synthesis or naturally via living orgs.
The Pharmaceutical Industry
FDA, Health Canada
Research Intensive + high risk + potentially high profit
“Ethical” Innovator (Research-based) Pharmaceutical Companies
invest heavily into research
discover and develop new molecular entities
ex: Pfizer, AstraZeneca, Johnson & Johnson
Generic Pharmaceutical Companies
do not discover new molecular entities
enter market through patent expiry/ challenges
specialize in manufacturing efficiency + drug formulations
ex: Novartis, Pfizer
Biotech Companies
exploit academic discoveries
Invest heavily in research
Focus on specialized products
ex: Moderna, BioNTech
Contract Research Organizations (CROs)
provide specialized services for the pharmaceutical industry:
Biological testing
Specialty chemical synthesis
Specialty manufacturing
Conduct clinical trials
Focus on specific research areas - niche expertise
ex: Paraza Pharma, Altasciences
Molecular Entity vs. Product
molecular entity
pure active ingredient
(e.g., Acetaminophen)
product
formulation that contains the molecular entity
(e.g. Tylenol)
Typical Drug Project Progression
Idea / Target Identification
Identify a drug target (enzyme, receptor, biological pathway)
Define a new drug strategy
Project initiation & feasibility: Can we do it? Should we do it?
Discovery
Identify a lead compound
Optimize the lead (potency, selectivity, stability)
Result: New Molecular Entity (NME)
Preclinical Development (Trials)
In vitro (lab) and in vivo (animal) studies
Assess safety, toxicity, dosing, pharmacokinetics (PK)
Develop drug formulation (e.g., pill, injection)
Clinical Development (Trials)
Phase I: Safety and dosage
Phase II: Efficacy and side effects
Phase III: Effectiveness in large populations
Confirm risk vs. benefit
Market & Post Market
Regulatory approval (FDA / Health Canada)
Post-marketing surveillance (long-term safety)
Identify new indications or uses
New Molecular Entity
(NME) -